Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24554

Xla Wt + Hsa.krasV12 : GFP + myh10 MO, Moruzzi M et al. (2021)

Experiment + Assay: Xla Wt + Hsa.krasV12 : GFP + myh10 MO + NF10 (3D imaging)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection myh10 MO1 myh10 (Xla)
 NF stage 6 (32-cell) blastomere
mRNA injection Tg(Hsa.krasV12 : GFP) kras (Xla)
 NF stage 6 (32-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
3D imaging NF stage 10 to NF stage 10  
Anatomical Phenotypes: abnormal mitotic cell
Source: Fig. S 4 F
Article: XB-ART-58186, PubMed